Skip to main content

Publications

featured publications

  • Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).

    Leukemia

    Authors: Andreas Burchert, Franck E Nicolini, Philipp le Coutre, Susanne Saussele, Andreas Hochhaus, Evin Tuere, Stephan K Metzelder, Kim Pauck, Holger Garn, Hartmann Raifer, Magdalena Huber, Norbert Gattermann, Martina Crysandt, Philippe Schafhausen, Matthias Bormann, Markus P Radsak, Agnès Guerci-Bresler, Thomas Illmer, Maria E Goebeler, Peter Herhaus, Lino L Teichmann, Georg-Nikolaus Franke, Fabian Lang, Stefan W Krause, Robert Möhle, Martine Klausmann, Frank Stegelmann, Christoph Lutz, Gabriel Etienne, Andrea Stoltefuß, Joachim R Göthert, Thomas Ernst, Maisun Abu-Samra, Heinz-Gert Höffkes, Andreas Neubauer, Ying Wang, Paul Weiland, Clara Otto, Lea Kiessler, Theresa Weber, Lea Kroning, Andrea Nist, Thorsten Stiewe, Rüdiger Hehlmann, Behnaz Aminossadati, Michael Wittenberg, Kerstin Winterstein, Thomas Oellerich, Marcus Lechner, Markus Pfirrmann, Carmen Schade-Brittinger, Paul Klemm, Christian Michel

  • Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms.

    Blood cancer journal

    Authors: Robert Meyer, Maria Jimena Rodriguez, Madeline Caduc, Kim Kricheldorf, Matthias Begemann, Florian Kraft, Isabel Spier, Daniela Dey, Nergis Güzel, Kerstin Becker, Julian Baumeister, Marcelo A S de Toledo, Susanne Isfort, Ulrich Germing, Stefan Aretz, Tim H Brümmendorf, Ingo Kurth, Miriam Elbracht, Lino L Teichmann, Steffen Koschmieder

  • NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.

    Nature communications

    Authors: Ruth-Miriam Koerber, Calvin Krollmann, Kevin Cieslak, Elisabeth Tregel, Maria L Saenz, Tim H Brümmendorf, Steffen Koschmieder, Martin Griesshammer, Ines Gütgemann, Conny K Baldauf, Thomas Fischer, Peter Brossart, Carl Christian Kolbe, Eicke Latz, Dominik Wolf, Lino L Teichmann

  • Tissue inflammation induced by constitutively active STING is mediated by enhanced TNF signaling.

    eLife

    Authors: Hella Luksch, Felix Schulze, David Geißler-Lösch, David Sprott, Lennart Höfs, Eva M Szegö, Wulf Tonnus, Stefan Winkler, Claudia Günther, Andreas Linkermann, Rayk Behrendt, Lino L Teichmann, Björn H Falkenburger, Angela Rösen-Wolff

  • MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.

    Annals of hematology

    Authors: Stefanie Jilg, Juliana Schwaab, Katja Sockel, Carl C Crodel, Valeska Brueckl, Frank Stegelmann, Madlen Jentzsch, Daniel Sasca, Margarete Moyses, Stephan Fuhrmann, Daniel Gundel, Madlen Caduc, Lino L Teichmann, Florian Heidel, Haifa K Al-Ali, Petro E Petrides

  • Refinement of the prognostic impact of somatic bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).

    HemaSphere

    Authors: Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, Sibylle Cocciardi, Claudia Lengerke, Ulrich Germing, Gerald Wulf, Maisun A Samra, Lino L Teichmann, Michael Lübbert, Michael W M Kühn, Martin Bentz, Jörg Westermann, Lars Bullinger, Verena I Gaidzik, Annika Meid, Sophia Aicher, Frank Stegelmann, Daniela Weber, Anika Schrade, Felicitas Thol, Michael Heuser, Arnold Ganser, Axel Benner, Hartmut Döhner, Konstanze Döhner

  • Platelet transcription factors license the pro-inflammatory cytokine response of human monocytes.

    EMBO molecular medicine

    Authors: Ibrahim Hawwari, Lukas Rossnagel, Nathalia Rosero, Salie Maasewerd, Matilde B Vasconcelos, Marius Jentzsch, Agnieszka Demczuk, Lino L Teichmann, Lisa Meffert, Damien Bertheloot, Lucas S Ribeiro, Sebastian Kallabis, Felix Meissner, Moshe Arditi, Asli E Atici, Magali Noval Rivas, Bernardo S Franklin

  • Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.

    Annals of hematology

    Authors: Susanne Isfort, Kirsi Manz, Lino L Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R Göthert, Thomas Illmer, Philippe Schafhausen, Haifa Kathrin Al-Ali, Frank Stegelmann, Mathias Hänel, Tim Pfeiffer, Aristoteles Giagounidis, Georg-Nikolaus Franke, Steffen Koschmieder, Alice Fabarius, Thomas Ernst, Mareille Warnken-Uhlich, Uta Wolber, Denise Kohn, Markus Pfirrmann, Dominik Wolf, Tim H Brümmendorf

  • Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN).

    Leukemia

    Authors: Frank Stegelmann, Lino L Teichmann, Florian H Heidel, Carl C Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder

  • Nestin expression in osteocytes following myeloablation and during bone marrow metastasis.

    British journal of haematology

    Authors: Ruth-Miriam Koerber, Rebekka K Schneider, Jessica Ellen Pritchard, Lino L Teichmann, Udo Schumacher, Peter Brossart, Ines Gütgemann